skip to main content

Our Private Equity Group provides trusted counsel derived from deep industry knowledge to established as well as up-and-coming private equity firms. We represent firms of every size across the spectrum of investment strategies, and we build long-standing relationships with our clients. As active participants in the private equity industry, we are able to advise our clients on the latest innovations, as well as current market practices and trends.

Nutraceutical to Be Acquired by HGGC

Paul, Weiss is representing Nutraceutical International Corporation in its $446 million acquisition by HGGC, LLC, a leading middle-market private equity firm. The transaction includes cash as well as debt. Under the terms of the agreement, announced on May 22, Nutraceutical stockholders will receive $41.80 in cash for each outstanding share of Nutraceutical common stock, which represents a 49 percent premium to Nutraceutical’s closing stock price on May 19, and a 15.6 percent premium to its all-time high closing stock price. The transaction is expected to close in the second half of 2017. Nutraceutical manufactures and markets branded nutritional supplements and bulk formulations for sale to health food stores and other nutritional industries.

The Paul, Weiss team included corporate partners Jeffrey Marell, Ted Ackerman and David Huntington and counsel Frances Mi; employee benefits partner Lawrence Witdorchic; real estate partner Salvatore Gogliormella; litigation partner Stephen Lamb; intellectual property partner Claudine Meredith-Goujon; antirust counsel Marta Kelly; and environmental counsel William O’Brien.

May 18, 2017

© 2019 Paul, Weiss, Rifkind, Wharton & Garrison LLP

Privacy Policy